JERLYN MCCLEOD: Open Payments
NPI 1972659407 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 99 payments from 15 companies in 2025. Trend: 2023 $1,624 · 2024 $3,010 · 2025 $1,844
Food & beverage: $1,844
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $383 |
| Corium, LLC | 16 | $323 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $190 |
| ABBVIE INC. | 15 | $170 |
| Otsuka America Pharmaceutical, Inc. | 13 | $161 |
| Almatica Pharma LLC | 7 | $158 |
| Janssen Pharmaceuticals, Inc | 6 | $122 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Tris Pharma Inc | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
Products named: FANAPT, Azstarys, CAPLYTA, VRAYLAR, LOREEV XR, REXULTI, SPRAVATO, Dyanavel XR.
Industry payments across AL — which companies pay providers there.
